Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.
Galun E, Terrault NA, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S.
Galun E, et al.
J Hepatol. 2007 Jan;46(1):37-44. doi: 10.1016/j.jhep.2006.08.019. Epub 2006 Oct 20.
J Hepatol. 2007.
PMID: 17112624
Clinical Trial.